Dr. Berislav Bošnjak, research associate at the Institute of Immunology of the MHH, is now a member of our Cluster of Excellence. A warm welcome!
The research focus of the 44-year-old researcher is on the initiation of the T-cell immune response and its function in infections and allergies. At the moment, he is mainly using cytomegalovirus infections as a model system. “My interest is to find out more about T-cell immune responses and the differences in dendritic cell migration patterns during homeostasis and infection,” says the immunologist.
Dr. Bošnjak studied molecular biology at the University of Zagreb, Croatia. He received his PhD from the University of Vienna, Austria, in 2015 and has been working at the Institute of Immunology at MHH since 2016. He will now enrich RESIST with his expertise in T-cell immunology and CRISPR/Cas9 technology, among other things. His goal is to one day be able to apply this technology to develop more effective and safer T-cell immunotherapies against viral infections.